Korean J Radiol.  2023 Sep;24(9):871-889. 10.3348/kjr.2023.0091.

Research Progress of CXCR4-Targeting Radioligands for Oncologic Imaging

• Wang Y
• Gao F

• KMID: 2545513
• DOI: http://doi.org/10.3348/kjr.2023.0091

Abstract

C-X-C motif chemokine receptor 4 (CXCR4) plays a key role in various physiological functions, such as immune processes and disease development, and can influence angiogenesis, proliferation, and distant metastasis in tumors. Recently, several radioligands, including peptides, small molecules, and nanoclusters, have been developed to target CXCR4 for diagnostic purposes, thereby providing new diagnostic strategies based on CXCR4. Herein, we focus on the recent research progress of CXCR4-targeting radioligands for tumor diagnosis. We discuss their application in the diagnosis of hematological tumors, such as lymphomas, multiple myelomas, chronic lymphocytic leukemias, and myeloproliferative tumors, as well as nonhematological tumors, including tumors of the esophagus, breast, and central nervous system. Additionally, we explored the theranostic applications of CXCR4-targeting radioligands in tumors. Targeting CXCR4 using nuclear medicine shows promise as a method for tumor diagnosis, and further research is warranted to enhance its clinical applicability.

Keyword

CXCR4; Radioligands; Nuclear medicine; Imaging; Neoplasm; Oncology; Cancer